Statins for older stroke patients with frailty
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at how well statins work in older stroke or TIA patients who are already taking them and also have some frailty. The goal is to understand if continuing statins is safe and helpful for this group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 70 years or older and had an ischemic stroke or mini-stroke (TIA) within the past 6 weeks.
- You were already taking a statin before your stroke or TIA.
- You have some level of frailty, meaning you may need help with daily tasks or have other health issues.
- You have not had a serious reaction to statins in the past.
- You can speak and understand Dutch, or have someone who can help you communicate.
- You can give your permission to be in the study, or have someone who can help with that.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether starting a statin soon after a stroke or mini-stroke helps older adults (70+) who are frail. You will be randomly assigned to receive a statin or a placebo to see if it reduces the chance of another stroke.
This trial tests whether starting a high dose of a statin (a cholesterol-lowering medicine) soon after a stroke can improve your cholesterol levels. It is for people who have had a stroke or have significant narrowing of arteries in the brain or neck.
This trial compares two treatments for people who recently had a stroke or TIA and have high cholesterol with artery plaque. Some participants will get a combination of two cholesterol-lowering medicines (statin and ezetimibe), while others will get only a statin.
This study tests if combining the blood thinner clopidogrel with either atorvastatin or rosuvastatin (both cholesterol-lowering drugs) works better for people who have had a mild first-time stroke in the small blood vessels of the brain. The goal is to find a safe and effective treatment regimen.
This trial studies whether continuing or stopping statin medicine after a spontaneous bleeding stroke in the brain (called lobar ICH) leads to better outcomes. It may help clarify if statins are safer to stay on—or better to pause—after this type of event.
This study looks at whether taking a low- to moderate-dose statin can prevent first-time heart and stroke problems in people age 70 and older. It may help you lower “bad cholesterol” (LDL) and see if that leads to fewer heart events over time.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.